Alafosfalin, a new inhibitor of cell wall biosynthesis: in vitro activity against urinary isolates in Japan and potentiation with beta-lactams.

Antimicrobial Agents and Chemotherapy
H B MaruyamaT Sawada

Abstract

A new phosphonopeptide, alafosfalin, was evaluated for in vitro antibacterial activity and for synergism with beta-lactams, using 475 Japanese clinical isolates from urinary tract infections. Alafosfalin was found to be highly active against Escherichia coli and moderately active against Serratia, Klebsiella, Enterobacter, and Citrobacter, but less active against gram-positive organisms than were beta-lactams such as cephazolin or ampicillin and inactive against indole-positive Proteus, Pseudomonas, and Acinetobacter. Potentiation with the two beta-lactams (fractional inhibitory concentration less than or equal to 0.5) was found in 10 to 40% of susceptible strains in 4:1 and 1:4 combinations, and to a lesser extent in those species or genera that were insensitive to alafosfalin alone. No cross resistance was seen between alafosfalin and the beta-lactams or any other commonly used antibacterial agents tested. Effect on selected ampicillin-resistant strains, differential sensitivity to alafosfalin among resistant strains of various types, and sensitivity of alafosfalin-insensitive E. coli and Klebsiella to other antibiotics are also discussed.

References

May 1, 1979·Antimicrobial Agents and Chemotherapy·J G AllenP S Ringrose
May 1, 1979·Antimicrobial Agents and Chemotherapy·F R AthertonP S Ringrose
May 1, 1979·Antimicrobial Agents and Chemotherapy·F R AthertonP S Ringrose

❮ Previous
Next ❯

Citations

Jan 1, 1981·Pharmacology & Therapeutics·F C Neuhaus, W P Hammes
Apr 1, 1981·Antimicrobial Agents and Chemotherapy·K WatanabeH B Maruyama
Oct 1, 1981·Antimicrobial Agents and Chemotherapy·F R AthertonD Westmacott
May 1, 1982·Antimicrobial Agents and Chemotherapy·M ArisawaH B Maruyama
Dec 22, 2015·Journal of Peptide Science : an Official Publication of the European Peptide Society·Juan Manuel Junior Cervera-VillanuevaMario Ordóñez
Jul 6, 2012·Bioorganic & Medicinal Chemistry Letters·Letícia V FaroMaria Cecília B V de Souza
Aug 1, 1986·Journal of Clinical and Hospital Pharmacy·A C Lafong, P G Murphy
Jan 5, 2019·Organic & Biomolecular Chemistry·Despina J BougioukouWilfred A van der Donk
Mar 27, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Emma C L MarrsJohn D Perry

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.